Prostate cancer vaccine - YM BioSciences

Drug Profile

Prostate cancer vaccine - YM BioSciences

Alternative Names: Norelin; Prostate cancer vaccine - Biostar; Prostate cancer vaccine - Star Biotech; YMB2002

Latest Information Update: 20 Jan 2011

Price : $50

At a glance

  • Originator Star Biotech
  • Class Cancer vaccines
  • Mechanism of Action Gonadotropin releasing hormone inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Prostate cancer

Most Recent Events

  • 02 Jun 2005 Data from a media release have been added to the adverse events and Cancer therapeutic trials sections
  • 04 Mar 2005 The vaccine is available for licensing (http://www.ymbiosciences.com)
  • 12 Jun 2003 Data from a media release have been added to the adverse events and Cancer therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top